The Cymbalta Pregnancy Registry
Status: | Recruiting |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/9/2019 |
Start Date: | July 2009 |
End Date: | December 2020 |
Contact: | The Cymbalta Pregnancy Registry Call Center |
Email: | pregnancyregistries@incresearch.com |
Phone: | 1-866-814-6975 |
The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are
exposed to Cymbalta (duloxetine) during pregnancy. This is an observational,
exposure-registration and follow-up registry.
exposed to Cymbalta (duloxetine) during pregnancy. This is an observational,
exposure-registration and follow-up registry.
Inclusion Criteria:
- Sufficient evidence (e.g., date or gestational age) to confirm that Cymbalta exposure
occurred during pregnancy
- Sufficient data to establish in which trimester of pregnancy the exposure to Cymbalta
first occurred (i.e., first, second or third trimester)
- Sufficient information to determine whether the pregnancy is prospectively or
retrospectively registered (i.e., whether the outcome of pregnancy was known at the
time of first contact with the Registry)
- Date the pregnancy exposure is reported to the Registry
- Source of the report (Health Care Professional or pregnant patient)
- Full contact information for the reporter and Health Care Professional willing and
able to provide accurate pregnancy-related information (name, address, phone number,
etc.)
Exclusion Criteria:
- Reported cases that do not meet the minimum criteria for Registry enrollment are
deemed ineligible.
We found this trial at
1
site
Wilmington, North Carolina 28405
Principal Investigator: Vikki Brown
Phone: 910-509-4700
Click here to add this to my saved trials